WO2026095901 - TABLET COMPOSITION COMPRISING BREXPIPRAZOLE OR A SALT THEREOF
National phase entry is expected:
Publication Number
WO/2026/095901
Publication Date
07.05.2026
International Application No.
PCT/TR2025/051255
International Filing Date
07.10.2025
Title **
[English]
TABLET COMPOSITION COMPRISING BREXPIPRAZOLE OR A SALT THEREOF
[French]
COMPOSITION DE COMPRIMÉ COMPRENANT DU BREXPIPRAZOLE OU UN SEL DE CELUI-CI
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
ATAK, Fadime Bilgehan
IPEK, Celaleddin
ATAMAN, Seval
GENCAL BOZKURT, Aynur
SARP, Onder
INAN, Fevzi
Priority Data
2024/014920
01.11.2024
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2072 | |
| EPO | Filing, Examination, Granting | 9194 | |
| Japan | Filing, Examination, Granting | 2142 | |
| South Korea | Filing, Examination, Granting | 2050 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,198
Contact Us
Abstract[English]
The present invention relates to a tablet composition comprises brexpiprazole or a salt thereof and at least one binder and at least one glidant, wherein glidant is colloidal silicon dioxide. Further, the present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient process.[French]
La présente invention concerne une composition de comprimé comprenant du brexpiprazole ou un sel de celui-ci et au moins un liant et au moins un agent d'écoulement, l'agent d'écoulement étant du dioxyde de silicium colloïdal. En outre, la présente invention concerne également un procédé simple, rapide, économique, permettant de gagner du temps et industriellement pratique.